You are aware Teva filed an ANDA for Integrilin with a paragraph IV challenge last January? It would be fun to get Teva's legal team to do the heavy lifting, then see Momenta beat it to market again. T'ain't exactly a blockbuster, though, about $300 million in sales.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.